Lysosomal Therapeutics IncCompany Details

Get alertedif Lysosomal Therapeutics Inc gets funded!
Lysosomal Therapeutics IncFunding history
Key people
United States
Detailed industries:biotechnology
Company description

Lysosomal Therapeutics Inc. (LTI) is dedicated to innovative small-molecule research and development in the field of neurodegeneration, yielding new treatment options for patients with severe neurological diseases.


Funding history

Create alert
Want to know when Lysosomal Therapeutics Inc gets funded?
Key people
Cornelis BeenDirector, Executive Officer
Kees BeenFounder, President and CEO
Robert CarpenterDirector, Executive Officer
Daniel GeffkenCFO
Dimitri KraincDirector, Scientific Founder, Chairman of the Scientific Advisory Board
Joseph MazzulliScientific Founder
Paula RaganChief Business Officer
Renato SkerljVice President of Drug Discovery and Preclinical Development
Edmund SybertzFounder
Peter T. Lansbury, Jr.Chief Scientific Officer
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!